Security key
03969K108
Arcutis Biotherapeutics, Inc. - COMMON STOCK (ARQT)
CUSIP: 03969K108
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 126,503,507
- Total 13F value
- $1,176,619,915
- Share change
- +1,279,402
- Put/Call ratio
- 60%
- SEC-reported price per share
- $9.30
- Number of holders
- 184
- Value change
- +$9,242,287
- Number of buys
- 103
- Number of sells
- 84
- Shares outstanding
- 123,454,843
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
184
Top holders
10
ARQT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2024
Previous quarter: Q1 2024
Arcutis Biotherapeutics, Inc. SEC filings
Arcutis Biotherapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03969K108
Recent filing periods:
Ownership snapshot
Top reported holders of ARQT - Arcutis Biotherapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
JENNISON ASSOCIATES LLC
Disclosed value leader
JENNISON ASSOCIATES LLC
Comparable rows
15/15
Latest evidence
31 Mar 2024
13F
Lead comparable stake: 9.9%
Showing 1-6 of 15 holder rows.
Quick read
JENNISON ASSOCIATES LLC leads the comparable SEC ownership view at 9.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens JENNISON ASSOCIATES LLC's linked filing trail.
Comparable ownership
Top 5
JENNISON ASSOCIATES LLC
9.9%
Frazier Life Sciences Management,...
7.1%
STATE STREET CORP
7.1%
SUVRETTA CAPITAL MANAGEMENT, LLC
6.4%
Rubric Capital Management LP
6.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| JENNISON ASSOCIATES LLC |
13F
Company
|
9.9%
|
$120,667,279
12,176,315 shares
|
— | 31 Mar 2024 |
| Frazier Life Sciences Management, L.P. |
13F
Company
|
7.1%
|
$87,062,164
8,785,284 shares
|
— | 31 Mar 2024 |
| STATE STREET CORP |
13F
Company
|
7.1%
|
$87,049,817
8,784,038 shares
|
— | 31 Mar 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
Company
|
6.4%
|
$78,064,013
7,877,297 shares
|
— | 31 Mar 2024 |
| Rubric Capital Management LP |
13F
Company
|
6.1%
|
$74,424,100
7,510,000 shares
|
— | 31 Mar 2024 |
| Polar Capital Holdings Plc |
13F
Company
|
5.6%
|
$68,239,487
6,885,922 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
184
Shares
126,503,507
Rows available
184
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
166
Q2 2024 holders
184
Holder diff
18
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend